These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 30214607)
1. Glucosamine decreases the stemness of human ALDH Hosea R; Hardiany NS; Ohneda O; Wanandi SI Oncol Lett; 2018 Oct; 16(4):4737-4744. PubMed ID: 30214607 [TBL] [Abstract][Full Text] [Related]
2. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway. Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291 [TBL] [Abstract][Full Text] [Related]
3. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066. Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424 [TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways. Lin C; Wang L; Wang H; Yang L; Guo H; Wang X J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622 [TBL] [Abstract][Full Text] [Related]
5. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway. Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115 [TBL] [Abstract][Full Text] [Related]
6. Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling. Xiong A; Yu W; Liu Y; Sanders BG; Kline K Mol Carcinog; 2016 May; 55(5):420-30. PubMed ID: 25648304 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells. Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586 [TBL] [Abstract][Full Text] [Related]
8. Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1). Jain MV; Jangamreddy JR; Grabarek J; Schweizer F; Klonisch T; Cieślar-Pobuda A; Łos MJ Cell Cycle; 2015; 14(13):2109-20. PubMed ID: 26030190 [TBL] [Abstract][Full Text] [Related]
9. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling. Kim D; Choi BH; Ryoo IG; Kwak MK Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist. Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210 [TBL] [Abstract][Full Text] [Related]
11. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer. Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560 [No Abstract] [Full Text] [Related]
12. 13 Wang L; Choi HS; Lee B; Choi JH; Jang YS; Seo JW Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33804152 [TBL] [Abstract][Full Text] [Related]
13. Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells. Arnold KM; Opdenaker LM; Flynn NJ; Appeah DK; Sims-Mourtada J Int J Radiat Biol; 2020 Apr; 96(4):434-447. PubMed ID: 31850822 [No Abstract] [Full Text] [Related]
14. A Preliminary Study of miR-144 Inhibiting the Stemness of Colon Cancer Stem Cells by Targeting Krüppel-Like Factor 4. Qiu Z; Tu L; Hu X; Zhou Z; Lin Y; Ye L; Cui C J Biomed Nanotechnol; 2020 Jul; 16(7):1102-1109. PubMed ID: 33308377 [TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Al-Dhfyan A; Alhoshani A; Korashy HM Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884 [TBL] [Abstract][Full Text] [Related]
16. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit. Lin CS; Bamodu OA; Kuo KT; Huang CM; Liu SC; Wang CH; Tzeng YM; Chao TY; Yeh CT Phytomedicine; 2018 Jul; 46():93-103. PubMed ID: 30097127 [TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking. Bidan N; Bailleul-Dubois J; Duval J; Winter M; Denoulet M; Hannebicque K; El-Sayed IY; Ginestier C; Forissier V; Charafe-Jauffret E; Macario M; Matsunaga YT; Meignan S; Anquez F; Julien S; Bonnefond A; Derhourhi M; Le Bourhis X; Lagadec C Proteomics; 2019 Nov; 19(21-22):e1800454. PubMed ID: 31430054 [TBL] [Abstract][Full Text] [Related]
18. Role of TGF-β1 in human breast cancer stem cells. Hariyanto NI; Purwandhita RP; Syahrani RA; Louisa M; Wanandi SI J Pak Med Assoc; 2021 Feb; 71(Suppl 2)(2):S84-S89. PubMed ID: 33785948 [TBL] [Abstract][Full Text] [Related]
19. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells. Li W; Zhang Q; Chen K; Sima Z; Liu J; Yu Q; Liu J BMC Complement Altern Med; 2019 Feb; 19(1):38. PubMed ID: 30709346 [TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness. Huang P; Li H; Ren L; Xie H; Chen L; Liang Y; Hu Y; Selistre-de-Araujo HS; Boussios S; Jhawar SR; Cui R; Zuo Q; Chen Q Transl Cancer Res; 2023 Dec; 12(12):3703-3717. PubMed ID: 38193000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]